NCT03960840
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03960840
Title CD19-specific CAR-T Cells in CLL/SLL and DLBCL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | AUT | AUS

Facility Status City State Zip Country Details
University of California LA Los Angeles California 90095 United States Details
Stanford University Medical Center Stanford California 94305-5826 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Uni of Chi Medi Ctr Hema and Onco Chicago Illinois 60637 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Mass Gen Hosp Cancer Center Boston Massachusetts 02114 United States Details
University of Pennsylvania Clinical Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37221 United States Details
St Davids South Austin Medical Ctr Austin Texas 78704 United States Details
Uni Of TX MD Anderson Cancer Cntr Houston Texas 77030 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Pierre-Bénite 69495 France Details
Novartis Investigative Site Rennes 35000 France Details
Novartis Investigative Site Frankfurt am Main Hesse 60590 Germany Details
Novartis Investigative Site Leipzig Saxony 04103 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Bergamo BG 24127 Italy Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Milan MI 20132 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Fukuoka Fukuoka 812-8582 Japan Details
Novartis Investigative Site Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site Bunkyo Ku Tokyo 113-8677 Japan Details
Novartis Investigative Site L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Novartis Investigative Site Salamanca Castille and León 37007 Spain Details
Novartis Investigative Site Badalona Catalonia 08916 Spain Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Córdoba 14004 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Seville 41013 Spain Details
Novartis Investigative Site Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field